PATENT CLAIM ANALYSIS

Application Number: 16156983
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "338000"]

Abstract:
The present invention provides an oral pharmaceutical composition and a usage thereof, comprising a pharmaceutically acceptable acidic medicinal auxiliary material whose surface is modified and dabigatran etexilate or pharmaceutically acceptable salts or aquo-complexes thereof. The present invention further provides a surface modification method for a medicinal auxiliary material.

Claim (Index 15):
The oral pharmaceutical composition of  claim 14 , wherein the alkaline substance for modification or acidic substance for modification to the acidic medicinal auxiliary material or alkaline medicinal auxiliary material are present in a ration by weight of up to 10%.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15636353', '15303176', '15308014', '14373163', '14779911']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7952811397872581
- 35 USC 102 Novelty (BERT): 0.5657756109989238
- Combined Prediction Score: 0.7723305869084247
- Mean Citation Score: 326.399218
- Max Citation Score: 490.60538
- Similarity Product: 329.07769256886365

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test